I’m trying to wrap my head around the future valuation of the company if they announce a vaccine or antibody treatment deal with someone like J&J. This Covid-19 is such a global problem that any effective treatment will add a billion dollars to a company’s market cap. If they announce something significant institutions will start buying big and it doesn’t seem like there are many shares available.